BioSpace News Archive

Sobi™, a North American affiliate of the international biopharmaceutical company Swedish Orphan Biovitrum AB (publ) (Sobi®), dedicated to rare diseases, in partnership with the Platelet Disorder Support Association (www.pdsa.org PDSA), a leading immune thrombocytopenia (ITP) advocacy organization in North America, today announced the launch of florio®ITP

EDO platform demonstrates potentially best-in-class safety and efficacy profile in addressing DMD and DM1 disease phenotypes Advancing rapidly to the clinic with first-in-human studies expected to initiate in early 2022

Biopharmaceutical company Alvotech has successfully completed a second round of its US$ 100 million private placement, for US$ 35 million.

Aurinia Pharmaceuticals Inc. announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™, based on an independent analysis issued by the Institute for Clinical and Economic Review in a revised Evidence Report issued on March 12, 2021.

Lovelace Biomedical will present a webinar in inhalation drug delivery for infectious diseases, including COVID-19.

Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, provides an update on the establishment of the Medicare Coverage of Innovative Technology (MCIT)

IGM Biosciences, Inc. (IGM), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced the appointment of Lisa L. Decker, Ph.D., to the newly created position of Chief Business Officer. Ms. Decker joins IGM with twenty years of experience in business development strategy, transactions and alliance management.

The Center for Cancer and Blood Disorders, a comprehensive cancer center serving 12,000 patients annually in North Texas, announced the practice will offer cancer patients and their caregivers COVID-19 vaccinations beginning tomorrow.

Centene Corporation and several members of the Pro Football Hall of Fame family are partnering to increase education and awareness around COVID-19 vaccines through a series of new 15-, 30- and 60-second public service announcements, with a particular focus on communities of color.

Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced the finalization of arrangements for the completion of the investigational new drug (“IND”) package for the company’s lead drug candidate and its submission to the United States Food and Drug Administration (“FDA”).